Home > Compound List > Product Information
Boc-Lys(Z)-OSu_Molecular_structure_CAS_34404-36-9)
Click picture or here to close

Boc-Lys(Z)-OSu

Catalog No. 15541 Name Sigma Aldrich
CAS Number 34404-36-9 Website http://www.sigmaaldrich.com
M. F. C23H31N3O8 Telephone 1-800-521-8956
M. W. 477.50754 Fax
Purity Email
Storage Chembase ID: 139287

SYNONYMS

IUPAC name
2,5-dioxopyrrolidin-1-yl (2S)-6-{[(benzyloxy)carbonyl]amino}-2-{[(tert-butoxy)carbonyl]amino}hexanoate
IUPAC Traditional name
2,5-dioxopyrrolidin-1-yl (2S)-6-{[(benzyloxy)carbonyl]amino}-2-[(tert-butoxycarbonyl)amino]hexanoate
Synonyms
Nε-Z-Nα-Boc-L-lysine hydroxysuccinimide ester
Nα-Boc-Nε-Cbz-L-赖氨酸 N-羟基琥珀酰亚胺酯
Nε-苄氧羰基-Nα-叔丁氧羰基-L-赖氨酸羟基琥珀酰亚胺酯
Nα-Boc-Nε-Z-L-lysine hydroxysuccinimide ester
Nα-Boc-Nε-Cbz-L-lysine N-hydroxysuccinimide ester
Nα-Boc-Nε-Z-L-赖氨酸羟基琥珀酰亚胺酯

DATABASE IDS

MDL Number MFCD00037915
PubChem SID 24849529
Beilstein Number 1559393
CAS Number 34404-36-9
EC Number 251-999-7

PROPERTIES

Empirical Formula (Hill Notation) C23H31N3O8
Melting Point 108-117 °C
Optical Rotation [α]20/D -20.5±1.5°, c = 2% in dioxane
MSDS Link Download
Storage Temperature -20°C
German water hazard class 3

DETAILS

Description (English)
Packaging
5, 25 g in poly bottle
Application
Reactant involved in:
• Cellular labeling and tumor MRI as a bimodal lipidic contrast agent1
• Synthesis of improved peptide prodrugs 5-ALA for photodynamic therapy2
• Design of high affinity peptide conjugates as markers for small peptide transporter PEPT1 (SLC15A1)3
• Preparation of human growth hormone derivatives containing PEG groups4
• Enantiodivergent asymmetric cyclization5
• Solid-phase synthesis of peptide-cationic steroid conjugates for antibacterial screening6
Description (简体中文)
包装
5, 25 g in poly bottle
Application
Reactant involved in:
• Cellular labeling and tumor MRI as a bimodal lipidic contrast agent1
• Synthesis of improved peptide prodrugs 5-ALA for photodynamic therapy2
• Design of high affinity peptide conjugates as markers for small peptide transporter PEPT1 (SLC15A1)3
• Preparation of human growth hormone derivatives containing PEG groups4
• Enantiodivergent asymmetric cyclization5
• Solid-phase synthesis of peptide-cationic steroid conjugates for antibacterial screening6

REFERENCES